Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
2024 · Nature Communications · 71 citations
https://doi.org/10.1038/s41467-024-47286-5
B
Bjørn‐Eivind Kirsebom
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
907
Citations
15
h-index
22
i10-index
Bjørn‐Eivind Kirsebom is an academic researcher from University Hospital of North Norway. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 15, co-authored 69 publications.
ORCID: 0000-0002-1413-9578Papers by this author
worksDemographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years
2020 · The Clinical Neuropsychologist · 42 citations
https://doi.org/10.1080/13854046.2020.1829068
Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease
2024 · Alzheimer s & Dementia · 19 citations
https://doi.org/10.1002/alz.14422
Depressive Symptoms and Amyloid Pathology
2025 · JAMA Psychiatry · 18 citations
https://doi.org/10.1001/jamapsychiatry.2024.4305
Neuronal plasma biomarkers in acute ischemic stroke
2024 · Journal of Cerebral Blood Flow & Metabolism · 11 citations
https://doi.org/10.1177/0271678x241293537
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer’s disease
2025 · EBioMedicine · 4 citations
https://doi.org/10.1016/j.ebiom.2025.105598
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat